Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
199.96
228.84
208.77
167.53
208.09
205.03
290.95
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
199.96
228.84
208.77
167.53
208.09
205.03
290.95
Raw Material Cost
145.70
148.94
158.22
103.78
148.75
142.97
152.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.99
7.44
6.72
5.98
6.00
7.53
8.29
Selling and Distribution Expenses
78.33
91.75
136.74
123.51
99.33
75.31
92.05
Other Expenses
0.58
0.38
1.92
1.57
1.10
0.91
1.93
Total Expenditure (Excl Depreciation)
236.81
251.92
320.84
248.95
265.07
234.89
272.14
Operating Profit (PBDIT) excl Other Income
-36.9
-23.1
-112.10000000000001
-81.4
-57
-29.900000000000002
18.799999999999997
Other Income
4.62
17.28
1.39
5.86
4.89
9.47
10.12
Operating Profit (PBDIT)
5.62
37.72
-86.01
-83.94
-26.34
9.76
58.45
Interest
6.99
7.44
6.72
5.98
6.00
7.53
8.29
Exceptional Items
-4.79
-5.00
-1.54
2.01
-6.75
-5.03
-7.19
Gross Profit (PBDT)
54.25
79.89
50.55
63.74
59.35
62.06
138.49
Depreciation
39.88
39.88
37.74
37.74
36.47
36.47
29.63
Profit Before Tax
-46.04
-14.61
-132.02
-125.65
-75.57
-39.26
13.34
Tax
-4.65
0.85
2.91
-4.16
-4.87
-5.36
2.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-37.14
-7.06
-130.78
-116.45
-63.55
-28.85
18.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-37.14
-7.06
-130.78
-116.45
-63.55
-28.85
18.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.45
-0.68
0.69
-0.75
-0.93
-0.95
-0.61
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-37.59
-7.73
-130.09
-117.20
-64.48
-29.80
17.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,728.61
1,765.75
1,772.81
1,903.59
2,006.32
2,132.21
2,160.12
Earnings per share (EPS)
-0.12
-0.02
-0.41
-0.37
-0.2
-0.09
0.06
Diluted Earnings per share
-0.12
-0.02
-0.41
-0.37
-0.2
-0.09
0.06
Operating Profit Margin (Excl OI)
-19.45%
-8.5%
-59.94%
-76.13%
-32.53%
-17.65%
6.43%
Gross Profit Margin
-3.08%
11.04%
-45.16%
-52.47%
-18.79%
-1.36%
14.77%
PAT Margin
-18.57%
-3.08%
-62.64%
-69.51%
-30.54%
-14.07%
6.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -12.59% vs 9.58% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -388.31% vs 94.08% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -95.10% vs 123.34% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -5.41% vs 10.45% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Harbin Medisan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
199.96
0
199.96
Other Operating Income
0.00
0.00
0.00
Total Operating income
199.96
0
199.96
Raw Material Cost
145.70
0
145.70
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.99
0
6.99
Selling and Distribution Expenses
78.33
0
78.33
Other Expenses
0.58
0.00
0.58
Total Expenditure (Excl Depreciation)
236.81
0
236.81
Operating Profit (PBDIT) excl Other Income
-36.85
0.00
-36.85
Other Income
4.62
0
4.62
Operating Profit (PBDIT)
5.62
0
5.62
Interest
6.99
0
6.99
Exceptional Items
-4.79
0
-4.79
Gross Profit (PBDT)
54.25
0
54.25
Depreciation
39.88
0
39.88
Profit Before Tax
-46.04
0
-46.04
Tax
-4.65
0
-4.65
Provisions and contingencies
0
0
0.00
Profit After Tax
-37.14
0
-37.14
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-37.14
0
-37.14
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.45
0
-0.45
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-37.59
0
-37.59
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,728.61
0
1,728.61
Earnings per share (EPS)
-0.12
0
-0.12
Diluted Earnings per share
-0.12
0
-0.12
Operating Profit Margin (Excl OI)
-19.45%
0%
0.00
-19.45%
Gross Profit Margin
-3.08%
0%
0.00
-3.08%
PAT Margin
-18.57%
0%
0.00
-18.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 20.00 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -12.59% vs 9.58% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -3.89% vs -24.77% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit -3.76 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -388.31% vs 94.08% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 41.71% vs -1,077.27% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.10 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -95.10% vs 123.34% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 103.21% vs -190.70% in Jun 2025
Quarterly - Interest
Interest 0.70 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -5.41% vs 10.45% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 16.67% vs -25.93% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -19.45%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
